Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

Evaluation of safety and pharmacokinetic parameters of the PTI5803 product Ended

2024-512472-35-00 Epilepsy 2024-07-23
Lu AF28996 in Patients With Parkinson's Disease Ended

2023-507785-12-00 Parkinson's Disease 2024-07-22
Evaluation of Safety, Tolerability, and Pharmacodynamic Effects of Topically Applied SUDO-286 in Psoriasis Ended

2023-509079-18-00 Plaque Psoriasis 2024-07-22
An open label, randomized, single-dose, two-sequence, two-period, crossover comparative bioavailability study to assess the pharmacokinetic … Ended

2023-510176-31-00 This study is a phase I trial, a single-dose, open labe 2024-07-22
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood Ended

2023-510263-35-00 Pharmacokinetic trial 2024-07-22
A Phase I, open-label, non-randomized study to evaluate the absorption, distribution, metabolism and excretion and pharmacokinetics of DLX31… Ended

2023-507959-29-00 Parkinson’s Disease 2024-07-19
A study to investigate immune challenge induced skin reactions with SAR445399, canakinumab and spesolimab compared with placebo, in healthy … Ended

2024-511241-19-00 Immuun system diseases 2024-07-19
A Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics and Safety of ANT3310 Combined with M… Ended

2024-512617-41-00 Renal impairment 2024-07-19
A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together Ended

2023-509488-26-00 Prevention of ischemic stroke in patients after an acut 2024-07-18
Investigation of pharmacokinetics, safety and tolerability of a single subcutaneous dose of NNC0487-0111 in participants with various degree… Ended

2023-509961-19-00 Obesity and Diabetes mellitus Typ 2 2024-07-18
An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian … Ended

2023-508149-42-00 Infertility in women undergoing assisted reproductive t 2024-07-16
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497 Ended

2023-508371-36-00 small cell lung cancer (SCLC), castration resistant pro 2024-07-15
A study to investigate the effect of oral ticagrelor on the pharmacokinetics of oral rosuvastatin when given in healthy participants Ended

2024-512197-99-00 Clinical trial healthy volunteer 2024-07-12
In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology. Ended

2024-514577-22-00 Cognitive Disorders including Alzheimer's Disease, Fron 2024-07-12
A Study to Learn How Different Forms of Study Medicine CTB-AVP Are Taken up Into the Blood and How It Is Taken up Into The Blood When Taken … Ended

2023-507117-10-00 Complicated urinary tract infection including pyeloneph 2024-07-09
A single-dose, open-label study of TX000045 in patients with CpcPH or IpcPH and HFpEF. Ended

2023-508969-32-00 Combined postcapillary and precapillary pulmonary hyper 2024-07-08
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with … Ended

2023-510472-31-00 Healthy Adult Participants 2024-07-05
A research study looking into the effect of NNC05190130 on blood levels of a birth control pill and emptying of the stomach in women after m… Ended

2023-507973-16-00 Healthy postmenopausal females (Type 2 Diabetes) 2024-07-04
A Single Ascending Dose, Single-Centre Study, to Assess Pharmacokinetics, Safety and Tolerability of a Single Intramuscular Dose of Bedaquil… Ended

2023-508810-41-00 Tuberculosis 2024-07-01
A study to learn about the taste of Vericiguat given in liquid form in healthy male participants aged 18 to 45 years Ended

2023-508447-52-00 Heart failure in children 2024-06-28
An Open-label, Single-group, Three-period, Fixed-sequence, Phase I Study to Assess the Pharmacokinetics of AZD6793 Tablets When Administered… Ended

2023-509002-30-00 Chronic obstructive pulmonary disease 2024-06-25
Fast-Acting Insulins and Their Post-Meal Effects in Type 1 Diabetes Ended

2023-509217-37-00 Type 1 Diabetes 2024-06-25
Effect of SAR445611 on inflammatory responses following LPS challenge study in healthy participants Ended

2024-511618-19-00 Immune system diseases 2024-06-24
A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C]… Ended

2024-512578-83-00 Not applicable - Healthy volonteers 2024-06-24